Meet the Committee Members

Meet the Committee Members

The AIM-HI Venture Competition review committees are comprised of a combination of world-class life sciences industry professionals, investors and entrepreneurs from within the extensive network of the National Foundation for Cancer Research, the non-profit affiliate of the AIM-HI Accelerator Fund.

This competition is designed to provide scientist-entrepreneurs with advising, coaching and continuous access to our valuable global network to advance their innovative oncology technologies that can save patients’ lives. Ready to do more? DONATE NOW and help us double the impact for scientist-entrepreneurs who are creating life-saving oncology innovations!

Judging Committee

Anna D. Barker, Ph.D. | Co-Chair

Chief Strategy Officer, Ellison Institute of Technology

Raju Kucherlapati, Ph.D. | Co-Chair

Paul C. Cabot Professor of Genetics & Professor of Medicine, Harvard Medical School

Webster Cavenee, Ph.D.

Distinguished Professor Emeritus, University of California, San Diego

Aleksandra Filipovic, M.D., Ph.D.

Head of Oncology, PureTech Health

Gary Gordon, M.D., Ph.D.

Senior Medical Advisor and Board Member, Global Coalition for Adaptive Research

Scott Lippman, M.D.

Distinguished Professor of Medicine & Associate Vice Chancellor for Cancer Research

Eva Martin, M.D.

Senior Director, Alliance and Asset Management, Roche Pharma Partnering

Tom Miller

Founder & Managing Partner, GreyBird Ventures

Kornelia Polyak, M.D., Ph.D.

Professor of Medicine, Dana-Farber Cancer Institute

Libia F. Scheller, Ph.D., MBA

Global Head Oncology-Cooperative Groups & Strategic Alliances, Bayer Health Care Pharmaceuticals

Selection Committee

Pamela Garzone, Ph.D. | Co-Chair

Chief Development Officer, Anixa Biosciences

Raju Kucherlapati, Ph.D. | Co-Chair

Paul C. Cabot Professor of Genetics & Professor of Medicine, Harvard Medical School

Webster Cavenee, Ph.D.

Distinguished Professor Emeritus, University of California, San Diego

Aleksandra Filipovic, M.D., Ph.D.

Head of Oncology, PureTech Health

Daniel Johnson, Ph.D.

Professor and Vice Chair of Research, Department of Otolaryngology, UC San Francisco

Matthew Lawler

Entrepreneur-In-Residence, Blackbird Laboratories

Scott Lippman, M.D.

Distinguished Professor of Medicine & Associate Vice Chancellor for Cancer Research

Eva Martin, M.D.

Senior Director, Alliance and Asset Management, Roche Pharma Partnering

Kornelia Polyak, M.D., Ph.D.

Professor of Medicine, Dana-Farber Cancer Institute

Michael Salgaller, Ph.D.

Supervisory Invention Development & Marketing Specialist, National Institutes of Health/National Cancer Institute

Fei Shen, Ph.D.

Managing Director, Boehringer Ingelheim Venture Fund USA

Matt Tremblay, Ph.D.

CEO, Blackbird Laboratories